ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280 | -99.9% | 2,995 | +69.1% | 0.03% | +86.7% |
| Q1 2022 | $208,000 | -56.6% | 1,771 | -50.2% | 0.02% | -69.4% |
| Q4 2021 | $479,000 | +116.7% | 3,558 | +111.5% | 0.05% | +133.3% |
| Q2 2021 | $221,000 | -19.9% | 1,682 | -5.9% | 0.02% | -55.3% |
| Q3 2020 | $276,000 | -56.3% | 1,787 | -67.4% | 0.05% | +27.0% |
| Q2 2019 | $631,000 | +173.2% | 5,483 | +179.2% | 0.04% | +184.6% |
| Q1 2019 | $231,000 | +1.8% | 1,964 | -43.5% | 0.01% | +8.3% |
| Q1 2018 | $227,000 | – | 3,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |